Randomized trial assesses bacterial vaginosis subtype prevalence in women, indicating health disparities and risk factors.
BACKGROUND: Bacterial vaginosis (BV) is common and characterized by heterogeneous presentations. We aimed to determine BV subtype prevalence among women attending a United States infectious diseases vaginitis specialty clinic at initial and follow-up visits and identify factors associated with BV subtypes. METHODS: Medical records from adult patients were reviewed, including demographics, visit frequency, STI history, symptoms, and diagnoses. Chi-square, Fisher's exact, and Wilcoxon rank-sum tests compared women with and without BV. Modified Poisson models with generalized estimating equations assessed associations between characteristics and BV subtypes. RESULTS: Between June 2021-December 2024, 149 patients were evaluated; 49 (32.9%) had BV at the initial visit. Recurrent BV was most common (n=27, 55.1%), followed by uncomplicated symptomatic BV (n=18, 36.7%), asymptomatic BV (n=3, 6.1%), and refractory BV (n=1, 2.0%). Black women were more likely than White women to have BV (adjusted relative risk [aRR] 3.92, 95% CI: 1.66-9.27), as were women with a pregnancy history (aRR 2.37, 95% CI: 1.23-5.03). No predictors were identified for uncomplicated BV. Recurrent BV was associated with younger age (≤25 years; aRR 4.29, 95% CI: 1.06-17.29), higher BMI (aRR 3.48 for BMI 25-29.9; aRR 3.06 for BMI ≥30), STI history (aRR 2.19, 95% CI: 1.05-4.57), and a pregnancy history (aRR 3.14, 95% CI: 1.22-8.06). CONCLUSIONS: High BV prevalence and frequent recurrent BV were observed. Race, obesity, STI history, and a pregnancy history were associated with recurrent BV. Further research is needed to characterize factors influencing recurrent BV to optimize sexual health outcomes.
No takes yet. Share an insight, caveat, or question.
Gerwen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: